Molecular Diagnostics Market Overview and Growth Rate Analysis 2026 by Top Key Players Companies: Abbott, Johnson & Johnson, BD, Agilent Technologies, Biocartis, BioFire Diagnostics, LLC, bioMérieux, Myriad Genetics, Novartis, QIAGEN, Siemens Healthineers

The report is a comprehensive exploration of global Molecular diagnostics market offering growth rates, size of the industry, competitive landscape information, factors to the contributing growth of the global Molecular diagnostics market and more.

Molecular diagnostics market is projected to record significant gains over the forthcoming timeframe. Molecular diagnostics is one of the most transformative and dynamic areas of diagnostics, leading to various advancements in research and treatment which are revolutionizing healthcare throughout a wide array of medical conditions and diseases. Based on the application landscape, the market is segmented into oncology testing, blood screening, genetic testing, and infectious disease. Among these, the genetic testing segment is projected to record a CAGR of around 11% between 2019 to 2020 owing to the increasing advancements in diagnostic tools enabling higher sensitivity and specificity.

Request Sample Copy Of this Premium Report at: https://www.marketstudyreport.com/request-a-sample/467710/?utm_source=Openpr.com&utm_medium=TS

With respect to technology, the market is bifurcated into sequencing, isothermal amplification, PCR, chips & microarrays, in situ hybridization, mass spectrometry, and others. Among these, the in situ hybridization (ISH) segment is slated to record a market valuation of more than $3 billion by 2026, owing to the technological advancements that are allowing low cost gene mapping and diagnostics. The term molecular diagnostics is a class of diagnostic tests that evaluate health of a person literally at a molecular level, measuring and detecting specific genetic sequences in RNA or DNA or the proteins they express.

Furthermore, genetic testing has grown from a niche field for rare disorders to a wide scope of applications for personal use and complex disease. Applications of clinical genetic testing range from medical disciplines, which includes carrier and diagnostic testing for inherited disorders; pharmacogenetic testing to guide individual drug selection, dosage and response; to screening of newborn for highly penetrant disorders; and pre-symptomatic and predictive testing for adult-onset and complex disorders.

Prominent Players in the Market
o Abbott Molecular
o Agilent (Dako)
o Analytik Jena AG
o Becton, Dickinson and Company
o Biocartis Group NV
o BioFire Diagnostics
o Biomerieux
o Bio-Techne
o Cepheid
o Johnson & Johnson
o MDxHealth
o Myriad Genetics, Inc
o Novartis (Grifols)
o Roche Diagnostics
o Siemens Healthcare

Molecular diagnostics has become an important part of disease management and therapy, used in applications areas like drug regimen selection, detection of predisposition to disease, patient stratification, toxicity avoidance, and therapeutic monitoring. This growing integrality of the industry is poised to help it grow significantly in coming years.

Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/467710/?utm_source=Openpr.com&utm_medium=TS

ISH is a technique allowing localization of a particular segment of nucleic acid within a histologic section. The fundamental basis of ISH is that nucleic acids if preserved effectively within a histologic specimen, could be discovered through the application of a corresponding strand of nucleic acid to which a reporter molecule is generally attached. The technique is specifically useful in neuroscience.
Other applications of ISH are microbiology, pathology, developmental biology, karyotyping, and phylogenetic analysis. From a regional frame of reference, Latin America molecular diagnostics market is expected to reach a valuation of more than $1 billion by 2026, which is attributable to the rising awareness about cost-effective molecular diagnostics options among general population.

Report Content
Chapter 1. Methodology
Chapter 2. Executive Summary
Chapter 3. Molecular Diagnostics Industry Insights
Chapter 4. Molecular Diagnostics Market, By Application
Chapter 5. Molecular Diagnostics Market, By Technology

Related Report:
Global Healthcare IT Market 2020 by Company, Regions, Type and Application, Forecast to 2025

The global Healthcare IT market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 12.1% in the forecast period of 2020 to 2025 and will expected to reach USD 210560 million by 2025, from USD 133350 million in 2019.
https://www.marketstudyreport.com/reports/global-healthcare-it-market-2020-by-company-regions-type-and-application-forecast-to-2025?utm_source=Openpr.com&utm_medium=TS

Contact Us:
Market Study Report LLC
4 North Main Street,
Selbyville, Delaware 19975
USA
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Email: sales@marketstudyreport.com
Website: https://www.marketstudyreport.com
Blog: https://www.marketstudyreport.com/blog

About Us:
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

This release was published on openPR.